These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 32344782)

  • 1. Does Medication-Related Osteonecrosis of the Jaw Influence the Quality of Life of Cancer Patients?
    Tenore G; Mohsen A; Rossi AF; Palaia G; Rocchetti F; Cassoni A; Valentini V; Ottolenghi L; Polimeni A; Romeo U
    Biomedicines; 2020 Apr; 8(4):. PubMed ID: 32344782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors affecting the quality of life of patients with medication-related osteonecrosis of the jaw during treatment: A quality-of-life survey and causal analysis.
    Munakata K; Miyashita H; Yamada Y; Soma T; Iwasaki R; Nakagawa T; Asoda S
    J Craniomaxillofac Surg; 2024 Jun; 52(6):715-721. PubMed ID: 38582669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality of life in cancer patients with or without medication-related osteonecrosis of the jaw.
    de Cassia Tornier S; Macedo FJ; Sassi LM; Schussel JL
    Support Care Cancer; 2021 Nov; 29(11):6713-6719. PubMed ID: 33973080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of medication-related osteonecrosis of the jaws on the quality of life in cancer patients.
    Caminha RD; Alcantara PL; Carvalho CG; Reia VC; Capelozza AL; Santos PS
    J Clin Exp Dent; 2020 Aug; 12(8):e725-e729. PubMed ID: 32913568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medication-related osteonecrosis of the jaws (MRONJ) and quality of life evaluation: a pilot study.
    Capocci M; Romeo U; Guerra F; Mannocci A; Tenore G; Annibali S; Ottolenghi L
    Clin Ter; 2017; 168(4):e253-e257. PubMed ID: 28703840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral Health-Related Quality of Life and Mental Health Impairment in Patients Affected by Medication-Related Osteonecrosis of the Jaws: A Case-Control Pilot Study.
    Calabria E; Antonelli A; Barone S; Adamo D; Salviati M; Cerra MG; Bennardo F; Giudice A
    Dent J (Basel); 2023 Jun; 11(6):. PubMed ID: 37366670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What is the effect of anti-resorptive drugs (ARDs) on the development of medication-related osteonecrosis of the jaw (MRONJ) in osteoporosis patients: A systematic review.
    Aljohani S; Fliefel R; Ihbe J; Kühnisch J; Ehrenfeld M; Otto S
    J Craniomaxillofac Surg; 2017 Sep; 45(9):1493-1502. PubMed ID: 28687467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Which symptoms negatively affect the oral health-related quality of life in patients with osteonecrosis of the jaw?
    Sato T; Kusumoto J; Takeda D; Kishimoto M; Kashin M; Furudoi S; Akashi M
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2020 Aug; 130(2):175-180. PubMed ID: 32493679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medication-related osteonecrosis of the jaw: risk factors in patients under biphosphonate versus patients under antiresorptive-antiangiogenic drugs.
    Ghidini G; Manfredi M; Giovannacci I; Mergoni G; Sarraj A; Mureddu M; Giunta G; Bonanini M; Meleti M; Vescovi P
    Minerva Stomatol; 2017 Aug; 66(4):135-140. PubMed ID: 28497661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medication-related osteonecrosis of the jaw: Prevention, diagnosis and management in patients with cancer and bone metastases.
    Otto S; Pautke C; Van den Wyngaert T; Niepel D; Schiødt M
    Cancer Treat Rev; 2018 Sep; 69():177-187. PubMed ID: 30055439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective Percutaneous Controlled Radiofrequency Thermocoagulation of the Gasserian Ganglion To Control Facial Pain Due to Medication-Related Osteonecrosis of the Jaw.
    Taniguchi A; Fukazawa K; Hosokawa T
    J Palliat Med; 2017 Oct; 20(10):1171-1174. PubMed ID: 28772087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparing the Influence of Surgical and Conservative Therapy on Quality of Life in Patients with Early-Stage Medication-Related Osteonecrosis of the Jaw-A Prospective Longitudinal Study.
    Rückschloß T; Smielowski M; Moratin J; Schnug G; Appel M; Muench P; Bleymehl M; Zittel S; Engel M; Hoffmann J; Ristow O
    Medicina (Kaunas); 2023 Jan; 59(2):. PubMed ID: 36837478
    [No Abstract]   [Full Text] [Related]  

  • 13. Is the prevalence of the medication-related osteonecrosis of the jaws underestimated, evaluation in oncological and non-oncological disease.
    Galis B; Zajko J; Hirjak D; Vanko L; Kupcova I; Jurkemik J; Gengelova P; Mikuskova K; Halmova K; Riznic M; Czako L
    Bratisl Lek Listy; 2017; 118(12):724-731. PubMed ID: 29322803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Prevention of Medication-related Osteonecrosis of the Jaw.
    Poxleitner P; Engelhardt M; Schmelzeisen R; Voss P
    Dtsch Arztebl Int; 2017 Feb; 114(5):63-69. PubMed ID: 28241916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-resorptive Drugs and their Impact on Maxillofacial Bone among Cancer Patients.
    Borumandi F; Aghaloo T; Cascarini L; Gaggl A; Fasanmade K
    Anticancer Agents Med Chem; 2015; 15(6):736-43. PubMed ID: 25807940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Position paper on medication-related osteonecrosis of the jaw (MRONJ)].
    Svejda B; Muschitz Ch; Gruber R; Brandtner Ch; Svejda Ch; Gasser RW; Santler G; Dimai HP
    Wien Med Wochenschr; 2016 Feb; 166(1-2):68-74. PubMed ID: 26847441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medication-related osteonecrosis of the jaw: Clinical and practical guidelines.
    Rosella D; Papi P; Giardino R; Cicalini E; Piccoli L; Pompa G
    J Int Soc Prev Community Dent; 2016; 6(2):97-104. PubMed ID: 27114946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet rich fibrin in the management of medication-related osteonecrosis of the jaw: a clinical and histopathological evaluation.
    Inchingolo F; Cantore S; Dipalma G; Georgakopoulos I; Almasri M; Gheno E; Motta A; Marrelli M; Farronato D; Ballini A; Marzullo A
    J Biol Regul Homeost Agents; 2017; 31(3):811-816. PubMed ID: 28958140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathological fracture of the coronoid process secondary to medication-related osteonecrosis of the jaw (MRONJ).
    Jowett A; Abdullakutty A; Bailey M
    Int J Surg Case Rep; 2015; 10():162-5. PubMed ID: 25841160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CT imaging features of antiresorptive agent-related osteonecrosis of the jaw/medication-related osteonecrosis of the jaw.
    Baba A; Goto TK; Ojiri H; Takagiwa M; Hiraga C; Okamura M; Hasegawa S; Okuyama Y; Ogino N; Yamauchi H; Kobashi Y; Yamazoe S; Munetomo Y; Mogami T; Nomura T
    Dentomaxillofac Radiol; 2018 May; 47(4):20170323. PubMed ID: 29365278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.